KIT and neoplasm: Given that c-Kit, a receptor for SCF, has been implicated in the pathogenesis of several neoplastic diseases including mastocytosis21, Arf1 inhibitor could also be applicable to mast cell proliferative disorders like Kit-mediated tumorigenesis.